Article info
PDFAsthma
Tumour necrosis factor (TNFα) as a novel therapeutic target in symptomatic corticosteroid dependent asthma
- Correspondence to:
Professor S T Holgate
Infection, Inflammation and Repair Division, F Level South Block (810), Southampton General Hospital, Southampton SO16 6YD, UK; sthsoton.ac.uk
Citation
Tumour necrosis factor (TNFα) as a novel therapeutic target in symptomatic corticosteroid dependent asthma
Publication history
- Received April 19, 2005
- Accepted August 4, 2005
- First published September 15, 2005.
Online issue publication
September 01, 2022
Article Versions
- Previous version (16 March 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 Thorax